Full Prescribing Information

Prescription NuvaRing^® is a flexible vaginal ring approved for the prevention of pregnancy in women.

For additional important information, please see the FULL PRODUCT INFORMATION, INCLUDING BOXED WARNING.

IMPORTANT SAFETY INFORMATION:

• The use of combination oral contraceptives is associated with increased risks of several serious side effects, including blood clots, which may lead to stroke or heart attack. NuvaRing^® is not for women with a history of these conditions. The risk of getting blood clots may be greater with the type of progestin in NuvaRing^® than with some other progestins in certain low-dose birth control pills. It is unknown if the risk of blood clots is different with NuvaRing^® use than with the use of certain birth control pills
• Cigarette smoking increases the risk of serious cardiovascular side effects, especially in women over 35; women who use combination hormonal contraceptives, including NuvaRing^®, are strongly advised not to smoke
• NuvaRing^® is not for women with certain cancers or those who may be pregnant. NuvaRing^® does not protect against HIV infection and other sexually transmitted diseases
• The most common side effects reported by NuvaRing^® users are: vaginal infections and irritation, vaginal secretion, headache, weight gain, and nausea

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.